INNV-31. THE USE OF IVOSIDENIB IN PATIENTS WITH ENHANCING IDH1 MUTANT GLIOMAS

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2024-11-01
DOI
https://doi.org/10.1093/neuonc/noae165.0693
Citations
1
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.37
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

INNV-31. THE USE OF IVOSIDENIB IN PATIENTS WITH ENHANCING IDH1 MUTANT GLIOMAS

Annick Desjardins, Mustafa Khasraw, Michal Nisnboym Ziv, Kristen A. Batich et al.
1 citations
Neuro-Oncology
Neuroblastoma Research and Treatments
0.37
article

INNV-31. THE USE OF IVOSIDENIB IN PATIENTS WITH ENHANCING IDH1 MUTANT GLIOMAS

Annick Desjardins, Mustafa Khasraw, Michal Nisnboym Ziv, Kristen A. Batich, Justin Low, Margaret Johnson, Henry S. Friedman, David M. Ashley, Mallika Patel, Katherine B. Peters, Madison L Shoaf, Maria Minor
article en
1 citations

Abstract

No abstract available for this paper.
Neuro-OncologyVol. 26(Supplement_8)
Duke University (US)
Good health and well-being
Openalex Percentile: Top 34%
Neuroblastoma Research and Treatments
0.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.